MARC details
000 -LEADER |
fixed length control field |
02449cam a22003257i 4500 |
001 - CONTROL NUMBER |
control field |
19095378 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210916t2013 enka b 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781118488133 : |
Terms of availability |
6,990 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
BSRU |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
C782E 2013 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Copeland, Robert Allen |
245 10 - TITLE STATEMENT |
Title |
Evaluation of enzyme inhibitors in drug discovery : |
Remainder of title |
a guide for medicinal chemists and pharmacologists / |
Statement of responsibility, etc. |
Robert A. Copeland |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Hoboken, N.J. : |
Name of publisher, distributor, etc. |
Wiley, |
Date of publication, distribution, etc. |
2013 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxx, 538 p. |
Other physical details |
ill. ; |
Dimensions |
22 cm. |
490 1# - SERIES STATEMENT |
Series statement |
Green chemistry |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
There has been explosive growth in the hunt for new pharmaceutically agents globally. Traditionally, this has been the purview of the pharmaceutical industry, but today, this effort crosses academic, government, and industry laboratories across the world. Enzymes remain the most valued and common of drug targets; hence, a detailed understanding of their interactions with inhibitors is critical to successful drug discovery. This book provides a practical, readable, and comprehensive treatment of these topics that allows scientists to master the art of applied enzymology for drug discovery. The book addresses the opportunities for inhibitor interactions with enzyme targets arising from consideration of the catalytic reaction mechanism; discusses how inhibitors are properly evaluated for potency, selectivity, and mode of action, covers the potential advantages and liabilities of specific inhibition modalities with respect to efficacy invivo, and provides valuable biochemical insights to help medicinal chemists and pharmacologists most effectively pursue lead optimization. It includes two new chapters, one on the pioneering idea of drug-target residence time fostered by Dr. Copeland, and the second on quantitative biochemistry. Five new appendices are added |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Enzyme inhibitors |
General subdivision |
Therapeutic use |
-- |
Testing |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Design |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemical engineering |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Green chemistry |
856 4# - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
ดูปกและสารบัญ (see cover and contents) |
Uniform Resource Identifier |
https://opacb.bsru.ac.th/book/File115204.pdf |
900 ## - EQUIVALENCE OR CROSS-REFERENCE-PERSONAL NAME [LOCAL, CANADA] |
Personal name |
21/10/26 |
901 ## - LOCAL DATA ELEMENT A, LDA (RLIN) |
a |
Chem. |
901 ## - LOCAL DATA ELEMENT A, LDA (RLIN) |
a |
new_oct21 |
940 ## - EQUIVALENCE OR CROSS-REFERENCE--UNIFORM TITLE [OBSOLETE] [CAN/MARC only] |
Uniform title |
31319 ห้องสมุด |
-- |
31320 C.2 บัณฑิต |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
General Books |
039 ## - |
-- |
1 |
-- |
STAFF MATRIX |